These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3008301)

  • 1. [Laboratory results in the evaluation of anti HTLV-III in subjects at risk].
    Maschio C; Colangeli S; Rughetti A; Fonzi D; Barnabei R; Ciccarella A
    Riv Emoter Immunoematol; 1985; 32(3):302-6. PubMed ID: 3008301
    [No Abstract]   [Full Text] [Related]  

  • 2. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML; Salassa B; Daziano E; Paggi GC
    Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of infections caused by AIDS and hepatitis B viruses in jailed people.
    Crovari P; Cassini U; Infante D; Guano F; Icardi GC; Auteri G; Di Ponzio A; Cuneo Crovari P
    Boll Ist Sieroter Milan; 1985; 64(5):367-70. PubMed ID: 3004543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HTLV-III serology, epidemiology and clinical aspects of imprisoned i.v. drug-dependent males in Austria].
    Pont J; Neuwald C; Kunz C; Werdenich W
    Wien Klin Wochenschr; 1986 Jul; 98(14):454-7. PubMed ID: 3019019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of anti-oncogenic virus antibodies in patients with malignancies, hemophilia and systemic lupus erythematosus.
    Lin KT; Liu MF; Hsieh RP; Lynn TC; Shen MC; Wang JH; Chen YC; Lai MY; Chen DS; Liu CH
    Taiwan Yi Xue Hui Za Zhi; 1985 Sep; 84(9):1025-32. PubMed ID: 3005471
    [No Abstract]   [Full Text] [Related]  

  • 6. False positive anti-HTLV III serology.
    Neale TJ; Dagger J; Fong R; Humble M; Meech P; Hatfield PJ; Morrison RB
    N Z Med J; 1985 Oct; 98(789):914. PubMed ID: 2997679
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rational microanalysis technic in the detection of antibodies to HTLV-III, CMV and EBV with indirect immunofluorescence].
    Stöcker W; Geusendam G; Schmitz H; Mohr H; Berndt H
    Beitr Infusionther Klin Ernahr; 1986; 15():51-7. PubMed ID: 3019301
    [No Abstract]   [Full Text] [Related]  

  • 8. Testing for HTLV-III/LAV antibody.
    Holston JL
    Ala J Med Sci; 1986 Jul; 23(3):269-71. PubMed ID: 3019171
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous drug abuse and the accident and emergency department: AIDS (HTLV-III) antibodies and hepatitis B markers.
    Dunlop MG; Steedman DJ; Peutherer JF
    Arch Emerg Med; 1986 Dec; 3(4):257-9. PubMed ID: 3026414
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antibodies against human T-cell leukemia virus (HTLV) in male homosexuals with acquired immunodeficiency syndrome].
    Kurth R; Brede HD; Bergmann L; Mitrou PS; Helm EB; Stille W
    MMW Munch Med Wochenschr; 1983 Dec; 125(48):1119-23. PubMed ID: 6318098
    [No Abstract]   [Full Text] [Related]  

  • 11. Before you test a patient for AIDS.... Ohio Department of Health recommendations for clinical management of individuals with HTLV-3 infection.
    Ohio State Med J; 1986 Aug; 82(8):533-7. PubMed ID: 3018646
    [No Abstract]   [Full Text] [Related]  

  • 12. Increasing prevalence of HTLV-III infection in intravenous drug users in Liguria, Italy.
    Cuneo Crovari P; Terragna A; Robert L; Orlando G; Rizzo F; Piuma-Fusco M; Icardi GC; Papa D; Di Ponzio A; Auteri G
    Boll Ist Sieroter Milan; 1985; 64(4):339-42. PubMed ID: 3000406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
    Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
    [No Abstract]   [Full Text] [Related]  

  • 14. HTLV-3 produces a broad range of illness.
    Fisher EJ
    Mich Med; 1986 Mar; 85(3):96-8. PubMed ID: 3007945
    [No Abstract]   [Full Text] [Related]  

  • 15. HTLV-III antibody in intravenous drug abusers of metropolitan Barcelona, Spain.
    Tor J; Muga R; Argelagues E; Rey-Joly C; Foz M; Ribas-Mundó M
    Arch Intern Med; 1986 Apr; 146(4):805. PubMed ID: 3008680
    [No Abstract]   [Full Text] [Related]  

  • 16. [Usefulness of the determination of anti-HTLV-III antibodies in parenteral drug addicts].
    Forteza-Rei J; Altés J; Villalonga C; Riera M
    Med Clin (Barc); 1986 Apr; 86(14):610. PubMed ID: 3014238
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatitis non-A, non-B diagnosis-by-exclusion].
    Dopatka HD; Behrens F
    Ric Clin Lab; 1983; 13 Suppl 1():41-56. PubMed ID: 6304858
    [No Abstract]   [Full Text] [Related]  

  • 18. Kaposi's sarcoma in Zaire is not associated with HTLV-III infection.
    Biggar RJ; Melbye M; Kestems L; Sarngadharan MG; de Feyter M; Blattner WA; Gallo RC; Gigase PL
    N Engl J Med; 1984 Oct; 311(16):1051-2. PubMed ID: 6090903
    [No Abstract]   [Full Text] [Related]  

  • 19. Virologic and immunologic study on acquired immune deficiency syndrome.
    Zhao JQ; Lin T; Ho MT
    Chin Med J (Engl); 1985 Jun; 98(6):442-3. PubMed ID: 2996840
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemic of LAV/HTLV III infection in drug addicts in Milan: serological survey and clinical follow-up.
    Lazzarin A; Galli M; Geroldi D; Zanetti A; Crocchiolo P; Aiuti F; Moroni M
    Infection; 1985; 13(5):216-8. PubMed ID: 2999002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.